Market Overview

Global Veterinary Vaccines Market size was valued at USD 10.49 Billion in 2023 and is poised to grow from USD 11.22 Billion in 2024 to USD 19.19 Billion by 2032, growing at a CAGR of 6.9 % in the forecast period (2024-2032).

The increased demand for pet care and animal needs together with increased awareness regarding animal health have formed a strongly growing segment in the animal health care sector driving the Global Veterinary Vaccines Market. They are essential for health and production in livestock or companion animals by avoiding a myriad of diseases that can affect them. The manufacturing and application of vaccines are the tools that ensure less mortality and control of infectious diseases in animals.

Pet and agricultural industries, having realized the relevance of vaccinations in disease control, have among others included preventive health care in their systems. Vaccination is a particular care exercise that helps to keep healthy and infestation-free flocks to avoid outbreaks of diseases whose direct consequence on production is profitability. Companion animal medical regimen would be incomplete without vaccinations.

There is some market growth in Veterinary Vaccines due to various factors. One of them is the global pet ownership boom due to changing lifestyles and the need for emotional satisfaction with pet companionship, which has subsequently increased the pet healthcare market, including vaccines. Furthermore, there are technology advancements in vaccines that have made the safety and efficacy of Veterinary Vaccines better. The impact of these improvements has been in the development of innovative vaccines, including those from recombinant DNA technology and other current approaches.

Meat, milk, and other animal products of high quality are also in high demand, thus putting the pressure on livestock health. Many countries across the globe have deemed livestock farming an important feature in food security and the economic stability of nations. Consequently, they and many other organizations are putting animal health as a priority through vaccination programs aimed at controlling disease outbreaks that stand to threaten food supply and disrupt trade globally.

The market further favors the passage of regulations aimed at improving vaccine safety and quality standards. Government interfaces such as subsidies for vaccination programs, and mandatory vaccination for the transportation of animals, all contribute to the increased adoption of Veterinary Vaccines. Public awareness campaigns and education regarding the importance of immunization of animal heads to the overall extent of market growth.

Market Drivers

Rising Awareness About Animal Health and Disease Prevention

• Awareness regarding animal health and disease prevention is a major boost to the Global Veterinary Vaccines Market. With increasing pet ownership in urban areas, there is an increasing trend of regular veterinary care, especially vaccinations. Pet owners are now more aware of the potential risks and diseases their animals may contract from zoonotic infections, such as rabies, parvovirus, and feline leukemia, prompting a higher demand for preventive healthcare.
• Even then, livestock farmers have come to realize the importance of vaccination in keeping the herd healthy and preventing disease outbreaks while boosting production. Infectious diseases in livestock could mean severe economic losses due to lowered productivity, trading limitations, or even the culling of infected animals. This makes farmers take a more dynamic approach to vaccination programs to keep their livestock safe from diseases like foot-and-mouth, brucellosis, and avian influenza.
• All of the above, along with public awareness campaigns, education programs, and news and media coverage, have helped coin stamp knowledge about animal health, which in turn results in the growing need for Veterinary Vaccines. This awareness not only improves the health and well-being of animals but also reduces the transmission of zoonoses-the diseases that can be spreading from animals to humans-protecting both animal and human health.

Growing Demand for High-Quality Meat and Livestock Products

• Global demand for meat and livestock products has encouraged expansion in the Global Veterinary Vaccines Market. As income rises, but mostly in emerging economies, so does the demand for protein-rich food- meat, eggs, and milk. This change has led many consumers to increasingly care about the quality and safety of the food that is consumed, affecting significantly meat and livestock products. This has made people more concerned about health in animals, particularly in the prevention of diseases that can affect the quality of meat and other livestock products.
• Therefore, the health of animals is important for livestock farmers since the consumers will pay for such meats as quality products, and it would also enhance the profit margin. The spread of diseases will incur a lot of economic losses among livestock farmers, whether through direct loss of animals or market and trade restrictions. Hence, farmers currently are increasingly turning to vaccines to protect their livestock from infectious diseases, which will improve animal welfare and ensure consistent high-quality production. Vaccination also conforms to international trade since many countries require proof of vaccination for animals before they can export. Hence, growing shopper demand for premium animal products is strongly related to the asking need for effective disease prevention strategies, fortifying Veterinary Vaccines in the industry.

Market Opportunities

Increasing Focus on Preventive Healthcare in Livestock Management

• One of the major determining trends which has been moving the Veterinary Vaccines Market in recent times is increased emphasis on preventive healthcare in livestock husbandry. Farmers and agrarian stakeholders are moving away from the traditional reactive approaches to proactive health management in order to improve livestock production, longevity, and welfare. Preventive health care-to include regular vaccination, disease surveillance, and biosecurity measures-clearly reduces the chances of outbreak of diseases that could cause mass death in herds or flocks. It involves vaccinating livestock against common infectious diseases such as brucellosis, foot-and-mouth disease, and avian influenza so that farmers can prevent costly epidemics, lower mortality rates, and reduce the use of antibiotics that help combat antibiotic resistance.
• Such perspectives are necessary in modern intensive farming systems in which animals are kept closely and the likelihood of transferring the disease from one to another is increased. They go a step further, not only protecting our animals but protecting the farmer's investment in production and quality of meat, milk, and other products from animals. They equally support the role that vaccination programs are likely to play in meeting the worlds rising demand for disease-free, high-quality animal products, particularly in foreign markets with stringent health and safety standards. Growing demands among consumers on food safety and sustainability issues have now also made preventive healthcare in livestock management an integral facet of agricultural practices that underscores the need for effective Veterinary Vaccines.

Market Restraining Factors

Stringent Regulatory Requirements for Vaccine Approval

• Stringent regulatory requirements for vaccine approval create a major restraint within the Veterinary Vaccines Market. After all, a variety of regulatory agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and World Health Organization (WHO) set across-the-board, rigorous standards to be met by all Veterinary Vaccines with regard to safety, efficacy, and quality prior to approval. Such regulations demand preclinical as well as clinical studies to validate that vaccines are safe for animals and effective for disease prevention.
• Such varying regulations often entail added testing, documentation, and compliance costs, thereby discouraging a smaller percentage of market players from searching for entry into the market. In addition to this, regulatory authorities strictly control the production, distribution, and post-market surveillance of these vaccines so that production is safe and continually monitored for adverse reactions. Although these regulations are highly critical for maintaining high standards in animal health, they can also slow down steps in innovation and act as barriers to companies preparing to launch new vaccines or improve existing formulations.

Segmentation Analysis

The market scope is segmented because of by Product, by Animal, by Route of Administration, by Distribution Channel.

By Product

Based on the Product of the market is segmented into Inactivated, Live Attenuated, Recombinant, Others.

The most dominating sectors as far as the Global Veterinary Vaccines Market is concerned are Inactivated vaccines, Live Attenuated vaccines, Recombinant vaccines, and Others. This is due to the generally wide application of inactivated vaccines, which are widely accepted and proven safe and efficacious in guarding against several infectious diseases in companion animals and livestock. Examples of inactivated vaccines which are made up of inactivated or killed viruses or bacteria include vaccines for rabies, foot-and-mouth disease, and avian influenza. They are more likely to be known for safety since they do not contain live pathogens and thus do not allow for disease development from the vaccine itself.

Inactivated vaccine preference is based on the simplicity with which the vaccines meet regulatory approval, often, they have simpler standards for standardization and control than live vaccines. They usually do not require any special care, have longer shelf life, and are thus suited for a distribution environment-rural and remote. Besides, inactivated vaccines can be administered together with adjuvants yielding strong immune-inducing effects for various diseases.

By Animal

Based on the Animal of the market is segmented into Companion, Livestock.

The major part of market comes from the livestock sector, quite simply because this sector also possesses a very significant role in agriculture and the increased demand for animal-based products. Livestock farming is almost entirely dependent on vaccination programs for the health and productivity of animals when it comes to those regions where meat, milk, or any animal-based product are lifelines for the economy.

This is because they need the vaccine for their livestock as it drives the quality appetite for meat as well as milk production. Apart from that, it's important to understand the fact that the whole world is moving towards food security measures based on global trade, and these have made vaccination programs a core element in meeting the global health and safety standards. There was always the importance of the government and international agencies in this regard, i.e. Proof of vaccination for animals before they could be exported is thus increasing the market of Veterinary Vaccines in livestock.

Regional Snapshots

Geographically, the report gives information on markets in Latin America, Asia-Pacific, Europe, North America, and MEA. North America now has a dominant position in the Global Veterinary Vaccines Market due to its sophisticated veterinary healthcare infrastructure, high pet ownership rates, and emphasis on livestock management. Particularly in the US and Canada, the animal health sectors are well settled, and there is strong immunization plan for livestock and companion animals. High-quality vaccinations that convince safety and benefit criteria are made available by the region's strong frameworks and advanced research and development capabilities. Further bolstering North America's leading position in the industry is the region's increasing demand for premium animal products, such as meat, dairy, and pet-related items.

The growing understanding of the value of animal health and the extensive use of vaccinations in livestock production, where preventing disease outbreaks is necessary to assisting output and satisfying international trade norms, are likewise advantageous to North America. The region's strong healthcare systems and consumers' enthusiasm to spend money on veterinary care specially for pet’s help explain why it leads the market.

List of Companies Profiled

• Elanco
• HIPRA
• Boehringer Ingelheim International GmbH
• Virbac
• MSD Animal Health
• Zoetis
• Ceva
• NEOGEN CORPORATION
• Hester Biosciences Limited

Key Industry Developments

• Boehringer Ingelheim formally unveiled Vaxxilive Cocci 3, a vaccine against chicken coccidiosis that was originally known as Hatchpak Cocci III, in January 2024. The purpose of the vaccination is to shield birds from coccidiosis.
• Jurox, an Australian animal health company that supplies veterinarian medications for the treatment of companion animals and cattle, was purchased by Zoetis in September 2022.
• In order to protect poultry in India against infectious bronchitis (IB) disease, Ceva introduced Cevac IBird in April 2022.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Veterinary Vaccines Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Global Veterinary Vaccines Market Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Veterinary Vaccines market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Veterinary Vaccines. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Veterinary Vaccines companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Veterinary Vaccines Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Veterinary Vaccines Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S.
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase

• To gain insightful analyses of the Veterinary Vaccines market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the Veterinary Vaccines market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the Veterinary Vaccines market. Besides the standard structure reports, we also provide custom research according to specific requirements.

Research Scope of Veterinary Vaccines Market

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Million

Veterinary Vaccines Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: